| Malignant Mixed Neoplasm studied in …STUDIED_INderived200 of 348show all (up to 200) |
|---|
| → studied in | NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Seromucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Seromucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04616560Phase 2 · recruiting Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061977Phase 3 · recruiting Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621718Phase 3 · recruiting Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858334Phase 2 · recruiting APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05920798Phase 1/Phase 2 · active not recruiting Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06647342Phase 4 · recruiting The Effect of Reduced Bleomycin in Electrochemotherapy Treatment · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Malignant Mixed Tumor of the Skin | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06674811recruiting Biomarkers of Resiliency In Childhood Cancer Surgery · condition mapped PROBABILISTIC · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07491445Phase 3 · recruiting Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00977574Phase 2 · active not recruiting Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651206Phase 2/Phase 3 · recruiting Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257528Phase 2 · active not recruiting Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07805954Phase 3 · recruiting Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04340141Phase 3 · active not recruiting Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06568172Phase 3 · suspended Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07573215approved for marketing Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02133196Phase 2 · recruiting T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839707Phase 2/Phase 3 · active not recruiting Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Seromucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660826Phase 2 · active not recruiting Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone · condition mapped PROBABILISTIC · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Lung Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04157127Phase 1 · recruiting Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03067181Phase 3 · recruiting Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Testicular Mixed Choriocarcinoma and Embryonal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04322318Phase 2 · recruiting A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Anaplastic Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06401330Phase 3 · recruiting A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Mixed Cell Type Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068794Phase 1/Phase 2 · active not recruiting MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Seromucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02466971Phase 3 · active not recruiting Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Vaginal Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929041Phase 2/Phase 3 · active not recruiting Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Lung Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04896073Phase 2 · completed Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP) · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172958Phase 1 · recruiting Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06543576Phase 1/Phase 2 · recruiting External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741968NA · recruiting A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05646316Phase 3 · recruiting Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580314Phase 3 · recruiting Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04715191Phase 1 · recruiting Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739800Phase 2 · active not recruiting Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Seromucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06822842completed Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595879Phase 1 · active not recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03180502Phase 2 · active not recruiting Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00379340Phase 3 · completed Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04622670NA · active not recruiting Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04623931Phase 2 · recruiting Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186847Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Lung Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213652Phase 2 · active not recruiting Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05581121Phase 3 · recruiting PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625190Phase 1/Phase 2 · recruiting Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04168788NA · completed Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07665684Phase 1/Phase 2 · not yet recruiting Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213704Phase 2 · active not recruiting Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05639972Phase 1/Phase 2 · recruiting E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Human Papillomavirus-Related Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05686226Phase 2 · recruiting E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Human Papillomavirus-Related Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05419479Phase 1/Phase 2 · suspended Switch Maintenance in Pancreatic · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352534Phase 3 · completed Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00945009Phase 3 · completed Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Adult Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00951496Phase 3 · completed Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Seromucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07454642Phase 1 · recruiting AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167712Phase 3 · active not recruiting Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Clear Cell Adenocarcinofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449108Phase 2 · active not recruiting LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07467772Phase 2 · recruiting Ph 2 Elacestrant in ER Positive Uterine Sarcomas · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Uterine Corpus Adenosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897321Phase 1 · recruiting B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04901702Phase 1/Phase 2 · recruiting Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898365completed Study of Kidney Tumors in Younger Patients · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Anaplastic Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05988918Phase 2 · active not recruiting Multicenter Trial of ESK981 in Patients With Select Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07584499Phase 1 · recruiting Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02192359Phase 1 · active not recruiting Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05049538recruiting Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05985161Phase 2 · recruiting A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01737619NA · active not recruiting PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483778Phase 1 · active not recruiting B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05156268Phase 2 · completed A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04968990Phase 2 · recruiting Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02874430Phase 2 · terminated Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03810651early Phase 1 · recruiting Pencil Beam Scanning in Patients With Renal Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04308330Phase 1 · recruiting Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02800486Phase 2 · recruiting Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03694262Phase 2 · completed The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07276360Phase 2 · recruiting Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919629Phase 2 · recruiting APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05384821Phase 1/Phase 2 · recruiting Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05500391Phase 2 · recruiting Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06483048Phase 1 · recruiting MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05494580Phase 1/Phase 2 · completed Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05103631Phase 1 · active not recruiting Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423484recruiting Therapeutic Recommendations for Nephroblastoma · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148050Phase 1 · recruiting Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01625351Phase 1 · completed A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07394413not yet recruiting Surgical Handling of Fertility-preserving Treatments for Cervical Adenocarcinomas · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04122872recruiting GISAR German Interdisciplinary Sarcoma Registry · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05542407Phase 1 · recruiting ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04377932Phase 1 · active not recruiting Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06115499Phase 2/Phase 3 · active not recruiting The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00565851Phase 3 · active not recruiting Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Clear Cell Adenocarcinofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422198Phase 3 · recruiting Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02364713Phase 2 · terminated MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05252416Phase 1 · terminated (VELA) Study of BLU-222 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618381Phase 1 · active not recruiting EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05973487Phase 1 · active not recruiting A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Human Papillomavirus-Related Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03738228Phase 1 · completed Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902988Phase 1/Phase 2 · recruiting A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02162732NA · completed Molecular-Guided Therapy for Childhood Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06198296Phase 1 · recruiting Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02111941early Phase 1 · completed Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Seromucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04574635active not recruiting Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05229601Phase 1 · terminated A Study of HFB301001 in Adult Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106414Phase 2 · active not recruiting Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639074Phase 2 · recruiting Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01849952terminated Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05195411completed Vascular Thrombus Involvement in Nephroblastoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04671693NA · active not recruiting A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Testicular Mixed Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153952Phase 1/Phase 2 · active not recruiting RT for Adenocarcinoma/Adenosquamous Carcinoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04681248no longer available Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03395080Phase 2 · completed A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04458597NA · completed Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393751Phase 1/Phase 2 · withdrawn Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01101451Phase 3 · completed Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513665Phase 2 · completed ZW25 in Women With Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04040231Phase 1 · completed Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03610490Phase 2 · terminated Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02026271Phase 1 · completed A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06923020enrolling by invitation Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer. · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Esophageal Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05337163completed A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00638898Phase 1 · completed Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Mixed Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06873672not yet recruiting Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735977NA · completed Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03552471Phase 1 · completed Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906382early Phase 1 · terminated Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01586104NA · completed Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805864Phase 2 · not yet recruiting Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03382158recruiting International PPB/DICER1 Registry · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220035Phase 2 · completed Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02076906Phase 1 · completed MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04791228Phase 2 · withdrawn A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05302921Phase 2 · completed Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03241745Phase 2 · completed A Study of Nivolumab in Selected Uterine Cancer Patients · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233204Phase 2 · completed Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03648489Phase 2 · completed Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06602661Phase 1 · not yet recruiting Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Lung Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206177Phase 1 · completed Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001282Phase 1/Phase 2 · terminated A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245123completed Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02164461Phase 1 · completed Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02624388Phase 2 · terminated Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01649089NA · unknown Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043391Phase 1 · completed Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06190574completed Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02923739Phase 2 · terminated Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Seromucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06288802unknown Study of Wilms Tumors Among Patients of Shefa Al-Orman Children Cancer Hospital · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015129Phase 2 · completed A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01661400Phase 1 · completed Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01922076Phase 1 · completed Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641287NA · terminated The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168270Phase 1 · terminated Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02536183Phase 1 · terminated A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01367301NA · terminated Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04688749terminated Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03215810Phase 1 · completed Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01992861terminated MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01721577Phase 1/Phase 2 · terminated Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00565903completed Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02921269Phase 2 · completed Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04956198completed Drug Sensitivity and Mutation Profiling · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03655587NA · completed Impact of an Orthotic Intervention in Children With Peripheral Neuropathy · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03072134Phase 1 · completed Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01414608Phase 3 · completed Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05600491Phase 3 · unknown A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01097746Phase 2 · completed First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Seromucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05537844unknown Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03834571Phase 2 · withdrawn Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01688388NA · completed Single Fraction Intraoperative Radiotherapy · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03924245Phase 1 · terminated Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers · condition mapped ALIAS · 348 trials mapped (105 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00303849Phase 1/Phase 2 · completed Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05265793Phase 2 · unknown Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03570437Phase 2 · unknown Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01307631Phase 2 · completed Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02982941Phase 1 · completed Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05224999Phase 2 · unknown Nivolumab for Recurrent/Metastatic Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05179850unknown Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02452554Phase 2 · completed Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01759355completed Hybrid PET/MR in the Therapy of Cervical Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01189266Phase 1/Phase 2 · completed Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma · condition mapped CURATED_BROADER · 348 trials mapped (105 active) | — | — | Anaplastic Oligoastrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00888615Phase 2 · completed Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 348 trials mapped (105 active) | — | — | Ovarian Seromucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |